KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) Equity Average (2016 - 2025)

Petmed Express' Equity Average history spans 15 years, with the latest figure at $28.3 million for Q4 2025.

  • For Q4 2025, Equity Average fell 28.22% year-over-year to $28.3 million; the TTM value through Dec 2025 reached $28.3 million, down 28.22%, while the annual FY2025 figure was $42.6 million, 22.58% down from the prior year.
  • Equity Average reached $28.3 million in Q4 2025 per PETS's latest filing, up from $11.9 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $128.7 million in Q2 2021 to a low of $4.4 million in Q4 2021.
  • Average Equity Average over 5 years is $61.3 million, with a median of $55.5 million recorded in 2022.
  • Peak YoY movement for Equity Average: crashed 93.63% in 2021, then soared 2414.82% in 2022.
  • A 5-year view of Equity Average shows it stood at $4.4 million in 2021, then skyrocketed by 2414.82% to $109.8 million in 2022, then fell by 29.35% to $77.6 million in 2023, then plummeted by 49.14% to $39.5 million in 2024, then decreased by 28.22% to $28.3 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Equity Average are $28.3 million (Q4 2025), $11.9 million (Q3 2025), and $42.6 million (Q2 2025).